Symbols / ONCO
ONCO Chart
About
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.02M |
| Enterprise Value | 417.65K | Income | -50.85M | Sales | 1.22M |
| Book/sh | 2.16 | Cash/sh | 0.54 | Dividend Yield | — |
| Payout | 0.00% | Employees | 5 | IPO | — |
| P/E | 0.00 | Forward P/E | -0.77 | PEG | — |
| P/S | 0.83 | P/B | 0.30 | P/C | — |
| EV/EBITDA | -0.09 | EV/Sales | 0.34 | Quick Ratio | 0.05 |
| Current Ratio | 0.08 | Debt/Eq | 4.93 | LT Debt/Eq | — |
| EPS (ttm) | 1229.73 | EPS next Y | -0.85 | EPS Growth | — |
| Revenue Growth | -25.40% | Earnings | 2023-11-17 17:00 | ROA | -7.41% |
| ROE | -221.37% | ROIC | — | Gross Margin | 85.41% |
| Oper. Margin | -6.81% | Profit Margin | 0.00% | Shs Outstand | 1.56M |
| Shs Float | 1.26M | Short Float | 8.47% | Short Ratio | 0.80 |
| Short Interest | — | 52W High | 36.30 | 52W Low | 0.62 |
| Beta | 3.45 | Avg Volume | 213.46K | Volume | 45.41K |
| Target Price | — | Recom | None | Prev Close | $0.70 |
| Price | $0.66 | Change | -5.88% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.66
Latest analyst target
3. DCF / Fair value
$73.78
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.66
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-09-13 | down | Maxim Group | Buy → Hold | — |
| 2023-04-26 | main | HC Wainwright & Co. | — → Buy | $9 |
| 2023-02-01 | reit | HC Wainwright & Co. | — → Buy | $7 |
| 2022-12-09 | init | HC Wainwright & Co. | — → Buy | $7 |
| 2022-12-08 | init | Maxim Group | — → Buy | $4 |
- Mall greeters and TV guests: Realbotix robots to reshape Onconetix strategy - Stock Titan hu, 12 Feb 2026 08
- Onconetix Stock Plunges On Realbotix Acquisition - Nasdaq hu, 12 Feb 2026 08
- XBOT: ONCO acquires RealLLC in an all-stock deal, with Realbotix gaining majority ONCO ownership - TradingView Fri, 13 Feb 2026 09
- Onconetix Shareholders Approve Flexible Reverse Stock Split Plan - TipRanks Mon, 09 Feb 2026 08
- Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders - Yahoo Finance Wed, 11 Jun 2025 07
- Is Onconetix Inc Gaining or Losing Market Support? - Benzinga Fri, 13 Feb 2026 17
- Onconetix Shares Cool Down Despite Strategic Moves and Developments - timothysykes.com hu, 12 Feb 2026 14
- Veru settles $8.8 million debt with Onconetix for cash, preferred stock, and warrants - Investing.com Fri, 26 Sep 2025 07
- Onconetix Signs Share Exchange Agreement With Realbotix - TradingView hu, 12 Feb 2026 13
- $12.9M Private Placement: Onconetix Restructures with Series D Stock Deal and Settles Major Veru Debt - Stock Titan Fri, 26 Sep 2025 07
- Onconetix to Acquire Realbotix, Pivot to Humanoid AI - TipRanks hu, 12 Feb 2026 08
- Onco-Innovations Revises Pricing on $2 Million Private Placement - TipRanks hu, 12 Feb 2026 08
- Onconetix Faces Triple Threat: Nasdaq Delisting Risk Over Missing Filings and 10-Cent Stock Price - Stock Titan hu, 22 May 2025 07
- Onconetix receives additional delisting notice from Nasdaq - Yahoo Finance Fri, 23 May 2025 07
- Onconetix to acquire Realbotix LLC in all-stock transaction - TipRanks hu, 12 Feb 2026 14
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 618 | — | — | Stock Award(Grant) at price 0.00 per share. | TARSH SIMON | Director | — | 2025-08-15 00:00:00 | D |
| 1 | 618 | — | — | Stock Award(Grant) at price 0.00 per share. | RAMDEEN TIMOTHY R. | Director | — | 2025-08-15 00:00:00 | D |
| 2 | 618 | — | — | Stock Award(Grant) at price 0.00 per share. | MEIER THOMAS PH.D. | Director | — | 2025-08-15 00:00:00 | D |
| 3 | 618 | — | — | Stock Award(Grant) at price 0.00 per share. | OAKLEY ANDREW J. | Director | — | 2025-08-15 00:00:00 | D |
| 4 | 1709 | — | — | Stock Award(Grant) at price 0.00 per share. | OAKLEY ANDREW J. | Director | — | 2025-03-21 00:00:00 | D |
| 5 | 177462 | — | — | Stock Award(Grant) at price 0.00 per share. | BRUHLMANN CHRISTIAN | Officer | — | 2024-12-20 00:00:00 | D |
| 6 | 177462 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHIESS RALPH | Chief Executive Officer | — | 2024-12-20 00:00:00 | D |
| 7 | 3318 | — | — | Stock Award(Grant) at price 0.00 per share. | SAPIRSTEIN JAMES E | Director | — | 2024-09-26 00:00:00 | D |
| 8 | 3318 | — | — | Stock Award(Grant) at price 0.00 per share. | TARSH SIMON | Director | — | 2024-09-26 00:00:00 | D |
| 9 | 3318 | — | — | Stock Award(Grant) at price 0.00 per share. | RAMDEEN TIMOTHY R. | Director | — | 2024-09-26 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -785.72K | -6.32K | 0.00 | 0.00 |
| TaxRateForCalcs | 0.02 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -12.69M | -17.94M | -13.47M | -3.41M |
| TotalUnusualItems | -44.91M | -18.77M | 61.41K | |
| TotalUnusualItemsExcludingGoodwill | -44.91M | -18.77M | 61.41K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -58.69M | -37.41M | -13.42M | -3.42M |
| ReconciledDepreciation | 731.35K | 43.94K | 6.75K | 4.89K |
| ReconciledCostOfRevenue | 1.47M | 1.19M | 0.00 | |
| EBITDA | -57.60M | -36.71M | -13.41M | -3.41M |
| EBIT | -58.33M | -36.75M | -13.42M | -3.42M |
| NetInterestIncome | -1.41M | -671.62K | 0.00 | 0.00 |
| InterestExpense | 1.41M | 671.62K | 0.00 | |
| InterestIncome | 18.00 | 0.00 | 0.00 | |
| NormalizedIncome | -14.57M | -18.65M | -13.48M | -3.42M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -58.69M | -37.41M | -13.42M | -3.42M |
| TotalExpenses | 12.86M | 17.91M | 13.48M | 3.42M |
| TotalOperatingIncomeAsReported | -56.49M | -36.03M | -13.48M | -3.42M |
| DilutedAverageShares | 32.30K | 5.03K | 3.61K | 3.21K |
| BasicAverageShares | 32.30K | 5.03K | 3.61K | 3.21K |
| DilutedEPS | -1.82K | -7.43K | -3.74K | -1.26K |
| BasicEPS | -1.82K | -7.43K | -3.74K | -1.26K |
| DilutedNIAvailtoComStockholders | -58.90M | -37.41M | -13.52M | -4.04M |
| NetIncomeCommonStockholders | -58.90M | -37.41M | -13.52M | -4.04M |
| PreferredStockDividends | 206.40K | 96.36K | 627.39K | |
| NetIncome | -58.69M | -37.41M | -13.42M | -3.42M |
| NetIncomeIncludingNoncontrollingInterests | -58.69M | -37.41M | -13.42M | -3.42M |
| NetIncomeContinuousOperations | -58.69M | -37.41M | -13.42M | -3.42M |
| TaxProvision | -1.05M | -12.59K | 0.00 | |
| PretaxIncome | -59.74M | -37.42M | -13.42M | -3.42M |
| OtherIncomeExpense | -48.00M | -18.90M | 61.41K | |
| OtherNonOperatingIncomeExpenses | -3.09M | -134.10K | ||
| SpecialIncomeCharges | -46.16M | -18.68M | 0.00 | |
| OtherSpecialCharges | 490.00K | |||
| WriteOff | 3.53M | 18.19M | 0.00 | |
| ImpairmentOfCapitalAssets | 42.63M | 0.00 | ||
| GainOnSaleOfSecurity | 1.25M | -91.97K | 61.41K | |
| NetNonOperatingInterestIncomeExpense | -1.41M | -671.62K | 0.00 | 0.00 |
| InterestExpenseNonOperating | 1.41M | 671.62K | 0.00 | |
| InterestIncomeNonOperating | 18.00 | 0.00 | 0.00 | |
| OperatingIncome | -10.33M | -17.85M | -13.48M | -3.42M |
| OperatingExpense | 11.39M | 16.72M | 13.48M | 3.42M |
| ResearchAndDevelopment | 154.36K | 1.95M | 4.13M | 1.33M |
| SellingGeneralAndAdministration | 11.23M | 14.77M | 9.35M | 2.09M |
| GeneralAndAdministrativeExpense | 11.23M | 14.77M | 9.35M | 2.09M |
| OtherGandA | 11.23M | 14.77M | 9.35M | 2.09M |
| GrossProfit | 1.06M | -1.13M | 0.00 | |
| CostOfRevenue | 1.47M | 1.19M | 0.00 | |
| TotalRevenue | 2.52M | 58.47K | 0.00 | 0.00 |
| OperatingRevenue | 2.52M | 58.47K | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| TreasurySharesNumber | 152.00 | 152.00 | 135.00 | |
| OrdinarySharesNumber | 138.29K | 6.57K | 4.49K | 3.21K |
| ShareIssued | 138.44K | 6.72K | 4.62K | 3.21K |
| NetDebt | 8.68M | 5.18M | ||
| TotalDebt | 9.45M | 9.89M | 0.00 | |
| TangibleBookValue | -18.51M | -86.69M | 22.39M | 1.45M |
| InvestedCapital | 17.87M | 4.14M | 22.39M | 1.45M |
| WorkingCapital | -17.34M | -11.35M | 22.34M | 1.44M |
| NetTangibleAssets | -17.44M | -86.69M | 22.39M | 1.45M |
| CapitalLeaseObligations | 119.43K | 148.54K | 0.00 | |
| CommonStockEquity | 8.54M | -5.60M | 22.39M | 1.45M |
| PreferredStockEquity | 1.07M | 11.00 | ||
| TotalCapitalization | 9.61M | -5.48M | 22.39M | 1.45M |
| TotalEquityGrossMinorityInterest | 9.61M | 1.40M | 22.39M | 1.45M |
| MinorityInterest | 0.00 | 7.01M | 0.00 | |
| StockholdersEquity | 9.61M | -5.60M | 22.39M | 1.45M |
| OtherEquityInterest | -250.31K | |||
| GainsLossesNotAffectingRetainedEarnings | -2.72M | 2.38M | 0.00 | |
| TreasuryStock | 625.79K | 625.79K | 566.81K | 0.00 |
| RetainedEarnings | -115.68M | -56.79M | -19.38M | -5.96M |
| AdditionalPaidInCapital | 127.83M | 49.43M | 42.33M | 7.40M |
| CapitalStock | 1.07M | 6.00 | 157.00 | 43.00 |
| CommonStock | 118.00 | 6.00 | 157.00 | 32.00 |
| PreferredStock | 1.07M | 0.00 | 0.00 | 11.00 |
| TotalLiabilitiesNetMinorityInterest | 18.57M | 86.11M | 3.92M | 1.64M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 280.88K | 68.92M | 0.00 | 0.00 |
| OtherNonCurrentLiabilities | 864.00K | |||
| PreferredSecuritiesOutsideStockEquity | 0.00 | 64.24M | 0.00 | |
| EmployeeBenefits | 280.88K | 556.30K | 0.00 | |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 280.88K | 556.30K | 0.00 | |
| DuetoRelatedPartiesNonCurrent | 0.00 | 864.00K | 0.00 | |
| TradeandOtherPayablesNonCurrent | 0.00 | 0.00 | 0.00 | |
| NonCurrentDeferredLiabilities | 0.00 | 3.07M | 0.00 | 0.00 |
| NonCurrentDeferredTaxesLiabilities | 0.00 | 3.07M | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 193.15K | 0.00 | |
| LongTermCapitalLeaseObligation | 0.00 | 74.29K | 0.00 | |
| LongTermDebt | 118.86K | |||
| CurrentLiabilities | 18.29M | 17.19M | 3.92M | 1.64M |
| OtherCurrentLiabilities | 43.09K | 2.64K | 14.02K | |
| CurrentDebtAndCapitalLeaseObligation | 9.45M | 9.69M | ||
| CurrentCapitalLeaseObligation | 119.43K | 74.25K | 0.00 | |
| CurrentDebt | 9.33M | 9.62M | ||
| OtherCurrentBorrowings | 9.33M | 9.62M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 186.96K | 487.58K | 1.13M | 234.26K |
| PayablesAndAccruedExpenses | 8.61M | 7.01M | 2.78M | 1.40M |
| CurrentAccruedExpenses | 662.03K | 1.65M | 1.10M | 821.25K |
| InterestPayable | 139.41K | 0.00 | ||
| Payables | 7.95M | 5.36M | 1.68M | 582.61K |
| DuetoRelatedPartiesCurrent | 4.12M | 0.00 | ||
| TotalTaxPayable | 40.00K | 60.53K | 177.60K | 0.00 |
| AccountsPayable | 3.79M | 5.30M | 1.50M | 582.61K |
| TotalAssets | 28.18M | 87.52M | 26.31M | 3.08M |
| TotalNonCurrentAssets | 27.23M | 81.68M | 52.71K | 11.50K |
| NonCurrentPrepaidAssets | 0.00 | 17.42K | 38.62K | 0.00 |
| NonCurrentDeferredAssets | 0.00 | 366.11K | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 27.05M | 81.09M | 0.00 | |
| OtherIntangibleAssets | 25.41M | |||
| Goodwill | 27.05M | 55.68M | 0.00 | |
| NetPPE | 182.32K | 209.20K | 14.09K | 11.50K |
| GrossPPE | 182.32K | 209.20K | 14.09K | 11.50K |
| OtherProperties | 182.32K | 209.20K | 14.09K | 11.50K |
| CurrentAssets | 950.27K | 5.84M | 26.26M | 3.07M |
| CurrentDeferredAssets | 0.00 | 757.65K | ||
| PrepaidAssets | 143.38K | 770.15K | 469.23K | 234.55K |
| Inventory | 64.08K | 364.05K | 0.00 | |
| FinishedGoods | 6.63K | 30.04K | 0.00 | |
| WorkInProcess | 0.00 | 194.81K | 0.00 | |
| RawMaterials | 57.45K | 139.21K | 0.00 | |
| Receivables | 96.31K | 149.73K | 35.85K | 152.52K |
| OtherReceivables | 41.84K | |||
| DuefromRelatedPartiesCurrent | 0.00 | 35.85K | 152.52K | |
| TaxesReceivable | 28.76K | 0.00 | ||
| AccountsReceivable | 25.72K | 149.73K | 0.00 | |
| CashCashEquivalentsAndShortTermInvestments | 646.50K | 4.55M | 25.75M | 1.93M |
| CashAndCashEquivalents | 646.50K | 4.55M | 25.75M | 1.93M |
| CashFinancial | 646.50K | 4.55M | 25.75M | 1.93M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -10.52M | -13.64M | -8.68M | -2.05M |
| RepurchaseOfCapitalStock | -718.00 | -58.98K | -566.81K | 0.00 |
| RepaymentOfDebt | -1.35M | -1.00M | 0.00 | |
| IssuanceOfDebt | 5.00M | 0.00 | ||
| IssuanceOfCapitalStock | 3.48M | 2.30M | 34.87M | 0.00 |
| CapitalExpenditure | -28.47K | -55.04K | -9.34K | -1.92K |
| InterestPaidSupplementalData | 379.41K | 0.00 | ||
| EndCashPosition | 646.50K | 4.55M | 25.75M | 1.93M |
| BeginningCashPosition | 4.55M | 25.75M | 1.93M | 4.31M |
| EffectOfExchangeRateChanges | -126.66K | -3.33K | 0.00 | |
| ChangesInCash | -3.78M | -21.19M | 23.82M | -2.38M |
| FinancingCashFlow | 6.74M | 1.04M | 32.53M | -334.19K |
| CashFlowFromContinuingFinancingActivities | 6.74M | 1.04M | 32.53M | -334.19K |
| NetOtherFinancingCharges | -400.00K | -205.09K | -1.77M | -334.19K |
| ProceedsFromStockOptionExercised | 6.32K | 459.00 | 3.09K | 0.00 |
| NetPreferredStockIssuance | 2.80M | 2.30M | 0.00 | |
| PreferredStockIssuance | 2.80M | 2.30M | 0.00 | |
| NetCommonStockIssuance | 684.56K | -58.98K | 34.30M | 0.00 |
| CommonStockPayments | -718.00 | -58.98K | -566.81K | 0.00 |
| CommonStockIssuance | 685.28K | 0.00 | 34.87M | 0.00 |
| NetIssuancePaymentsOfDebt | 3.65M | -1.00M | 0.00 | |
| NetLongTermDebtIssuance | 3.65M | -1.00M | 0.00 | |
| LongTermDebtPayments | -1.35M | -1.00M | 0.00 | |
| LongTermDebtIssuance | 5.00M | 0.00 | ||
| InvestingCashFlow | -28.47K | -8.65M | -32.66K | -1.92K |
| CashFlowFromContinuingInvestingActivities | -28.47K | -8.65M | -32.66K | -1.92K |
| NetOtherInvestingChanges | -9.65M | -23.33K | ||
| NetBusinessPurchaseAndSale | 0.00 | 1.06M | 0.00 | |
| SaleOfBusiness | 0.00 | 1.06M | 0.00 | |
| NetPPEPurchaseAndSale | -28.47K | -55.04K | -9.34K | -1.92K |
| PurchaseOfPPE | -28.47K | -55.04K | -9.34K | -1.92K |
| OperatingCashFlow | -10.50M | -13.58M | -8.68M | -2.04M |
| CashFlowFromContinuingOperatingActivities | -10.50M | -13.58M | -8.68M | -2.04M |
| ChangeInWorkingCapital | -1.54M | 1.62M | 2.56M | 1.21M |
| ChangeInOtherWorkingCapital | -9.64K | |||
| ChangeInOtherCurrentAssets | -7.75K | -16.88K | -38.62K | |
| ChangeInPayablesAndAccruedExpense | -2.61M | 2.43M | 2.83M | 1.15M |
| ChangeInAccruedExpense | -1.13M | -942.08K | 1.74M | 809.28K |
| ChangeInPayable | -1.48M | 3.37M | 1.09M | 336.71K |
| ChangeInAccountPayable | -1.48M | 3.37M | 1.09M | 336.71K |
| ChangeInPrepaidAssets | 1.02M | -412.60K | -234.68K | 193.24K |
| ChangeInInventory | -62.27K | -315.83K | 0.00 | |
| ChangeInReceivables | 116.68K | -62.29K | 0.00 | -114.96K |
| ChangesInAccountReceivables | 116.68K | -62.29K | 0.00 | |
| OtherNonCashItems | 4.40M | 1.64M | 263.92K | |
| StockBasedCompensation | 438.65K | 329.76K | 1.97M | 130.14K |
| ProvisionandWriteOffofAssets | 0.00 | 1.15M | ||
| AssetImpairmentCharge | 46.51M | 18.45M | 0.00 | 22.24K |
| DeferredTax | -1.05M | -12.59K | 0.00 | |
| DeferredIncomeTax | -1.05M | -12.59K | 0.00 | |
| DepreciationAmortizationDepletion | 731.35K | 43.94K | 6.75K | 4.89K |
| DepreciationAndAmortization | 731.35K | 43.94K | 6.75K | 4.89K |
| Depreciation | 6.75K | 4.89K | ||
| OperatingGainsLosses | -1.30M | 595.84K | -61.41K | 1.20K |
| PensionAndEmployeeBenefitExpense | -48.42K | 13.88K | 0.00 | |
| GainLossOnInvestmentSecurities | -1.25M | 91.97K | -61.41K | |
| GainLossOnSaleOfPPE | 0.00 | 1.20K | ||
| NetIncomeFromContinuingOperations | -58.69M | -37.41M | -13.42M | -3.42M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ONCO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|